Drugs.com - New Drug Approvals

FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy

ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of Miudella (copper intrauterine system) for the prevention...

Feb 26, 2025 - 07:20
 0
FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy
ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of Miudella (copper intrauterine system) for the prevention...
Read More

Tags:

Previous Article

29Metals trims annual loss but still has work to do

Next Article

Stations to get clearer announcements

Related Posts

FDA Approves Symvess (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

FDA Approves Symvess (acellular tissue engineered vesse...

Feb 9, 2025  0

FDA Approves Expanded Use of Soliris (eculizumab) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children

FDA Approves Expanded Use of Soliris (eculizumab) for P...

Mar 31, 2025  0

FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

FDA Approves Symbravo (meloxicam and rizatriptan) for t...

Feb 9, 2025  0